Epitopea

Cambridge, United Kingdom · Founded 2021 · Privately Held (backing)

Developer of transatlantic cancer immunotherapeutics designed to target a novel class of tumor-specific antigens. Epitopea is based in Cambridge, United Kingdom and was founded in 2021. It has raised $44.4 million.

Last price · $/share
—
Implied valuation
—
Total raised
$44.4M
Last round
—

Who backs Epitopea?

15 investors
InvestorType
Innovate UKOther
Investissement QuebecOther
Meltwind Advisory—
Jonathan Milner—
Fonds de solidarite FTQOther
Cambridge Innovation CapitalVenture capital
Advent Life Sciences—
BIOQuébec—
BioIndustry Association—
CQDM—
+ 5 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Epitopea investors

15 investors are on record for Epitopea, including Innovate UK, Investissement Quebec, Meltwind Advisory and Jonathan Milner.

Free account
More of Epitopea with a free account
  • ·The complete investor list: 15 names
  • ·Watch Epitopea: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 15 firms already write checks for companies like Epitopea. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View